Lianne McHardy, Ph.D. - Publications


11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Riffell JL, Zimmerman C, Khong A, McHardy LM, Roberge M. Effects of chemical manipulation of mitotic arrest and slippage on cancer cell survival and proliferation. Cell Cycle (Georgetown, Tex.). 8: 3025-38. PMID 19713760 DOI: 10.4161/Cc.8.18.9623  0.56
2009 Kemmer D, McHardy LM, Hoon S, Rebérioux D, Giaever G, Nislow C, Roskelley CD, Roberge M. Combining chemical genomics screens in yeast to reveal spectrum of effects of chemical inhibition of sphingolipid biosynthesis. Bmc Microbiology. 9: 9. PMID 19144191 DOI: 10.1186/1471-2180-9-9  0.56
2008 Sturgeon CM, Cinel B, Díaz-Marrero AR, McHardy LM, Ngo M, Andersen RJ, Roberge M. Abrogation of ionizing radiation-induced G2 checkpoint and inhibition of nuclear export by Cryptocarya pyrones. Cancer Chemotherapy and Pharmacology. 61: 407-13. PMID 17440726 DOI: 10.1007/S00280-007-0483-Y  0.56
2007 Diaz-Marrero AR, Gray CA, McHardy L, Warabi K, Roberge M, Andersen RJ. Antiangiogenic Alkaloids from Marine Organisms Modern Alkaloids: Structure, Isolation, Synthesis and Biology. 233-269. DOI: 10.1002/9783527621071.ch9  0.56
2005 McHardy LM, Warabi K, Andersen RJ, Roskelley CD, Roberge M. Strongylophorine-26, a Rho-dependent inhibitor of tumor cell invasion that reduces actin stress fibers and induces nonpolarized lamellipodial extensions. Molecular Cancer Therapeutics. 4: 772-8. PMID 15897241 DOI: 10.1158/1535-7163.Mct-04-0310  0.56
2004 Warabi K, McHardy LM, Matainaho L, Van Soest R, Roskelley CD, Roberge M, Andersen RJ. Strongylophorine-26, a new meroditerpenoid isolated from the marine sponge Petrosia (Strongylophora) corticata that exhibits anti-invasion activity. Journal of Natural Products. 67: 1387-9. PMID 15332859 DOI: 10.1021/Np0340246  0.56
2004 Baetz K, McHardy L, Gable K, Tarling T, Rebérioux D, Bryan J, Andersen RJ, Dunn T, Hieter P, Roberge M. Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action. Proceedings of the National Academy of Sciences of the United States of America. 101: 4525-30. PMID 15070751 DOI: 10.1073/Pnas.0307122101  0.56
2004 McHardy LM, Sinotte R, Troussard A, Sheldon C, Church J, Williams DE, Andersen RJ, Dedhar S, Roberge M, Roskelley CD. The tumor invasion inhibitor dihydromotuporamine C activates RHO, remodels stress fibers and focal adhesions, and stimulates sodium-proton exchange. Cancer Research. 64: 1468-74. PMID 14973060 DOI: 10.1158/0008-5472.Can-03-2733  0.56
2002 Williams DE, Craig KS, Patrick B, McHardy LM, van Soest R, Roberge M, Andersen RJ. Motuporamines, anti-invasion and anti-angiogenic alkaloids from the marine sponge Xestospongia exigua (Kirkpatrick): isolation, structure elucidation, analogue synthesis, and conformational analysis. The Journal of Organic Chemistry. 67: 245-58. PMID 11777468 DOI: 10.1021/Jo016101C  0.56
2001 Roskelley CD, Williams DE, McHardy LM, Leong KG, Troussard A, Karsan A, Andersen RJ, Dedhar S, Roberge M. Inhibition of tumor cell invasion and angiogenesis by motuporamines. Cancer Research. 61: 6788-94. PMID 11559552  0.56
2001 Britton R, De Silva ED, Bigg CM, McHardy LM, Roberge M, Andersen RJ. Synthetic transformations of eleutherobin reveal new features of its microtubule-stabilizing pharmacophore [20] Journal of the American Chemical Society. 123: 8632-8633. PMID 11525686 DOI: 10.1021/Ja016459Q  0.56
Show low-probability matches.